Anna Paola Lucarelli
Overview
Explore the profile of Anna Paola Lucarelli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
501
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Prosdocimi T, Mollica L, Donini S, Semrau M, Lucarelli A, Aiolfi E, et al.
Biochemistry
. 2018 Apr;
57(19):2876-2888.
PMID: 29652483
Selected members of the large rolipram-related GEBR family of type 4 phosphodiesterase (PDE4) inhibitors have been shown to facilitate long-term potentiation and to improve memory functions without causing emetic-like behavior...
2.
Nardone V, Lucarelli A, Dalle Vedove A, Fanelli R, Tomassetti A, Belvisi L, et al.
J Med Chem
. 2016 Apr;
59(10):5089-94.
PMID: 27120112
Cadherins are transmembrane cell adhesion proteins whose aberrant expression often correlates with cancer development and proliferation. We report the crystal structure of an E-cadherin extracellular fragment in complex with a...
3.
Rigoldi F, Gautieri A, Dalle Vedove A, Lucarelli A, Vesentini S, Parisini E
Proteins
. 2016 Feb;
84(6):744-58.
PMID: 26873906
Amadoriases, also known as fructosyl amine oxidases (FAOX), are enzymes that catalyze the de-glycosylation of fructosyl amino acids. As such, they are excellent candidates for the development of enzyme-based diagnostic...
4.
Fanzani L, Porta F, Meneghetti F, Villa S, Gelain A, Lucarelli A, et al.
Curr Med Chem
. 2015 Aug;
22(27):3110-32.
PMID: 26264920
Mycobacterium tuberculosis (Mtb), the main aetiological agent of tuberculosis (TB) in humans, is estimated to cause nearly two million deaths every year. Despite their huge therapeutic value, existing antitubercular drugs...
5.
Dalle Vedove A, Lucarelli A, Nardone V, Matino A, Parisini E
Acta Crystallogr F Struct Biol Commun
. 2015 Apr;
71(Pt 4):371-80.
PMID: 25849494
Cadherins are a large family of calcium-dependent proteins that mediate cellular adherens junction formation and tissue morphogenesis. To date, the most studied cadherins are those classified as classical, which are...
6.
Neres J, Pojer F, Molteni E, Chiarelli L, Dhar N, Boy-Rottger S, et al.
Sci Transl Med
. 2012 Sep;
4(150):150ra121.
PMID: 22956199
The benzothiazinone BTZ043 is a tuberculosis drug candidate with nanomolar whole-cell activity. BTZ043 targets the DprE1 catalytic component of the essential enzyme decaprenylphosphoryl-β-D-ribofuranose-2'-epimerase, thus blocking biosynthesis of arabinans, vital components...
7.
Manina G, Bellinzoni M, Pasca M, Neres J, Milano A, de Jesus Lopes Ribeiro A, et al.
Mol Microbiol
. 2010 Jul;
77(5):1172-85.
PMID: 20624223
Tuberculosis is still a leading cause of death in developing countries, for which there is an urgent need for new pharmacological agents. The synthesis of the novel antimycobacterial drug class...
8.
Makarov V, Manina G, Mikusova K, Mollmann U, Ryabova O, Saint-Joanis B, et al.
Science
. 2009 Mar;
324(5928):801-4.
PMID: 19299584
New drugs are required to counter the tuberculosis (TB) pandemic. Here, we describe the synthesis and characterization of 1,3-benzothiazin-4-ones (BTZs), a new class of antimycobacterial agents that kill Mycobacterium tuberculosis...
9.
Milano A, Pasca M, Provvedi R, Lucarelli A, Manina G, de Jesus Lopes Ribeiro A, et al.
Tuberculosis (Edinb)
. 2008 Oct;
89(1):84-90.
PMID: 18851927
Tuberculosis (TB) remains the leading cause of mortality due to a bacterial pathogen, Mycobacterium tuberculosis. Moreover, the recent isolation of M. tuberculosis strains resistant to both first- and second-line antitubercular...